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Left Main Bifurcation Lesion Treated
With Bioresorbable Scaffold V-Stenting
Tadashi Miyazaki, MD,*yz Vasileios F. Panoulas, MD, PHD,*yx Katsumasa Sato, MD,*y Hiroyoshi Kawamoto, MD,*y
Toru Naganuma, MD,*y Azeem Latib, MD,*y Antonio Colombo, MD*yA 66-year-old diabetic woman, who had per-formed percutaneous coronary intervention(PCI) with an Absorb bioresorbable vascular
scaffold (BVS) (Abbott Vascular, Santa Clara, Califor-
nia) in a left main bifurcation lesion with V-stenting
technique (Figures 1A and 1B), presented with recur-
rent effort angina 5 months after the index procedure.
Coronary angiography revealed signiﬁcant in-scaffold
restenosis in both ostia (Figure 1C). The patient
refused surgical revascularization, hence the decision
was made to undergo PCI. Initial optical coherence
tomography (OCT) imaging demonstrated marked
neointimal hyperplasia covering the scaffold with
the exception of the tip of the plastic neocarina.
The hyperplastic neointima exhibited a homogenous,
high-backscattering morphological pattern with,
however, an area of reduced backscatter adjacent to
the plastic neocarina (Figure 2). In addition, there
was no evidence of distinct scaffold disruption or
fracture, whereas there was some evidence for scaf-
fold recoil as indicated by a reduction in the scaffold
area (0.56 mm2, at the site of the minimal lumen area)
(Figure 2). This ﬁgure lies within the previously
reported 6-month follow-up minimal scaffold areaFrom the *Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbu
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(1) (0.05  0.78 mm2, OCT) and the study by Tani-
moto et al. (2) (0.65  1.71 mm2, intravascular ultra-
sound). The contribution and impact of this amount
of recoil on restenosis remain unknown. Possible
causes of in-scaffold restenosis in the current case
include: 1) neointimal proliferation accelerated by
concomitant comorbidities, such as insulin depen-
dent diabetes, and/or local ﬂow disturbances pro-
ducing low wall shear stress at the lateral walls of
the bifurcation; and 2) thrombus formation and sub-
sequent organization at the divider side (3), where
areas of low backscatter were seen on OCT (despite
dual antiplatelet therapy). It remains unknown
whether: 1) strut thickness (157  191 mm) and design
of BVS promotes more unfavorable ﬂow disturbances
compared with thin-strut metallic stents; and 2) the
low backscatter on OCT adjacent to the plastic neo-
carina could represent organized thrombus (4).
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FIGURE 1 Angiogram of Index and Follow-Up Procedure, and Follow-Up OCT Images
(A and B) Coronary angiograms of index procedure demonstrating left main bifurcation lesion (Medina 0, 1, 1) successfully treated with bio-
resorbable vascular scaffold using V-stenting technique. (C) Repeat coronary angiogram revealed in-scaffold restenotic lesions (Medina 0, 1, 1).
(D) Cross-sectional optical coherence tomography (OCT) images at repeat procedure demonstrating excessive neointima proliferation at the
bifurcation site. Yellow arrow indicates uncovered struts at the tip of the plastic neocarina. Blue asterisks indicate calcium deposits. LAD ¼ left
anterior descending coronary artery; LCx ¼ left circumﬂex coronary artery; LMS ¼ left main stem; MLA ¼ minimal lumen area.
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FIGURE 2 Comparison of OCT Images Between the Index and the Repeat Procedure
(A) Upper line: Index procedure: optimal ﬁnal OCT result demonstrating well apposed scaffolds on ﬁbrocalciﬁc plaque. Lower line: 5-month
follow-up: OCT demonstrating restenotic lesion consisting of concentric and homogeneous, high-backscattering neointima developed even
over calciﬁed segments (blue asterisks). Numbers represent scaffold area. (B) Left: index procedure: magniﬁed OCT images of bifurcation
demonstrating the plastic neocarina (white arrow). Right: 5-month follow-up: hyperplastic neointima with areas of low backscatter
(red arrowhead), adjacent to struts. Dotted lines indicate the thickness of the neocarina. Abbreviations as in Figure 1.
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